Autopsy report · NCT03606655

Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK

“Terms could not be met with the FDA.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

University of Florida

Sponsor type

University, hospital or other

Conditions

Kava on the Metabolism of Nicotine and NNK

Interventions

Kava

Participants

0

Trials that died the same way

• Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
  “FDA request as study could not serve as the confirmatory trial.” (77% match in meaning)
• Iontophoresis in Psoriasis
  “FDA did not provide approval of the use of the drug for the study” (74% match in meaning)
• Safety and Efficacy of Baricitinib for COVID-19
  “Could not make FDA required changes” (69% match in meaning)
• RCT of Epinephrine (None, 100mcg, and 200mcg) in a Hyperbaric Bupivacaine, Fentanyl and Morphine Spinal in C-sections.
  “Due to FDA constraints on the off label use of the medications we will not be able to conduct this evaluation.” (67% match in meaning)
• Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More
  “Feasibility of the clinical trial could not be confirmed at the different sites.” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.